Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1Phase 1 1

Status

Recruiting 2Active not recruiting 1

Sponsor Class

INDUSTRY 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 49Tumor-Agnostic 40Genitourinary 30Thoracic 29Breast 29Head & Neck 25Gynecologic 21Dermatologic 13Sarcoma 12CNS 9Other hematologic neoplasm 5Lymphoid 5Endocrine 3NET 2Myeloid 2Plasma cell 1

Conditions

Neuroendocrine Tumors 28Pheochromocytoma 11Adrenocortical Carcinoma 11Carcinoma, Neuroendocrine 10Thyroid Neoplasms 9Thyroid Cancer, Papillary 9Pituitary Neoplasms 9Sarcoma 7Small Cell Lung Carcinoma 6Paraganglioma 6Neoplasms 6Adrenal Gland Neoplasms 6Parathyroid Neoplasms 5Ovarian Neoplasms 5Melanoma 5Cholangiocarcinoma 5Carcinoid Tumor 5Pancreatic Neoplasms 4Neuroblastoma 4Multiple Endocrine Neoplasia Type 1 4Insulinoma 4Central Nervous System Neoplasms 4Carcinoma, Renal Cell 4Carcinoma, Non-Small-Cell Lung 4Carcinoma, Hepatocellular 4Stomach Neoplasms 3Osteosarcoma 3Neoplasm Metastasis 3Meningioma 3Lung Neoplasms 3

Interventions

Topotecan 1Specimen Handling 1Magnetic Resonance Spectroscopy 1Irinotecan 1Biopsy 1BAY 1895344 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Neoplasm Metastasis × Endocrine × 30 days × Clear all
NCT07377487 2026-05-22

INDIGO

Boston Scientific Corporation

Phase NA Recruiting
51 enrolled
EndocrineGastrointestinalNET

Carcinoma, Colonic Diseases, Digestive System Diseases, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasm Metastasis, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Colorectal Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT04514497 2026-05-19

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic Cancer

National Cancer Institute (NCI)

Phase 1 Active not recruiting
29 enrolled 25 charts
EndocrineGastrointestinalThoracic

Lung Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Carcinoma, Neuroendocrine, Small Cell Lung Carcinoma

NCT07129252 2026-05-11

BRAVESST2

Crinetics Pharmaceuticals Inc.

Phase 1/2 Recruiting
150 enrolled
EndocrineNET

Neoplasm Metastasis, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡